AML Overview
Seattle Cancer Care Alliance brings together the leading research teams and cancer specialists of Fred Hutch, Seattle Children's, and UW Medicine. One extraordinary group whose sole mission is the pursuit of better, longer, richer lives for our patients. Learn More


The medical team at Seattle Children’s, a founding organization of Seattle Cancer Care Alliance (SCCA), has a long history of successfully caring for children and teens who have leukemia. Renowned specialists from Children’s and SCCA work together to improve your child’s quality of life and conquer leukemia.

This section covers information you'll need to know about acute myelogenous leukemia (AML). In general, leukemia is cancer of the blood. It begins in the bone marrow where blood cells are produced. In leukemia, there are too many underdeveloped cells in the blood and bone marrow. These crowd out normal, healthy blood cells that the body needs.

Acute myelogenous leukemia (AML) is one of the most common kinds of childhood leukemia. AML can arise from several different types of early blood cells, including those that develop into white blood cells, red blood cells, or platelets.

Cancer Care Success Rates

Read about Seattle Children’s success rates for treating pediatric cancers.

Bone Marrow Transplant

If your child’s condition requires a bone marrow transplant, you should know that the Fred Hutch Transplant Program at SCCA was ranked first in outcomes in a multi-year study by the National Marrow Donor Program that measured one-year survival rates of patients at 122 transplant centers in the United States. The Hutch pioneered the use of bone marrow transplants as a treatment for blood diseases more than 40 years ago. Since then thousands of patients with leukemia have come from around the world to receive bone marrow transplants at SCCA. Bone marrow transplants have transformed leukemia and related cancers, once thought incurable, into highly treatable diseases with survival rates as high as 80 percent.